Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Centessa Pharmaceuticals plc (CNTA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Feb 2024
Rotman Harris
SVP Regulatory Affairs, Officer
Centessa Pharmaceuticals plc
(CNTA)
62,625
-6%
4,267
$8.10
$34,574.22
SELL
20 Sep 2023
Rotman Harris
SVP Regulatory Affairs, Officer
Centessa Pharmaceuticals plc
(CNTA)
33,500
-52%
37,484
$6.29
$235,688.16
SELL
1 Jun 2023
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
783,066
-0%
6,500
$4.45
$28,949.05
SELL
24 May 2023
Bush Tia L
Chief Quality Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
3,000
-72%
8,000
$4.48
$35,865.30
SELL
1 May 2023
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
789,566
-0%
6,800
$4.42
$30,083.20
SELL
31 Mar 2023
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
796,366
-0%
6,700
$3.69
$24,729.70
SELL
1 Mar 2023
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
806,681
-0%
7,000
$3.42
$23,970.10
SELL
1 Feb 2023
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
813,681
-0%
7,700
$3.79
$29,200.71
SELL
31 Dec 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
751,913
-0%
6,970
$3.18
$22,136.02
SELL
1 Dec 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
761,151
-1%
9,400
$3.91
$36,743.66
SELL
1 Nov 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
765,059
-1%
9,700
$4.03
$39,055.11
SELL
30 Sep 2022
HUSSAIN IQBAL J
General Counsel, Officer
Centessa Pharmaceuticals plc
(CNTA)
154,712
-5%
8,288
$4.00
$33,175.37
SELL
30 Sep 2022
Shahidi Javad
Chief Medical Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
158,932
-3%
6,068
$4.00
$24,289.08
SELL
1 Aug 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
800,174
-1%
10,423
$4.45
$46,405.28
SELL
18 Jul 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
810,597
-2%
20,000
$4.87
$97,312.00
SELL
1 Jul 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
730,597
-1%
9,100
$5.03
$45,796.66
BUY
24 Jun 2022
SAHA SAURABH
Chief Executive Officer, Director, Officer
Centessa Pharmaceuticals plc
(CNTA)
38,000
+35%
10,000
$4.63
$46,284.00
SELL
17 Jun 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
739,697
-1%
9,200
$4.68
$43,035.76
SELL
17 May 2022
YVER ANTOINE
EVP & Chairman of Development, Officer
Centessa Pharmaceuticals plc
(CNTA)
748,897
-10%
85,000
$5.17
$439,733.78
BUY
2 Feb 2022
SAHA SAURABH
Chief Executive Officer, Director, Officer
Centessa Pharmaceuticals plc
(CNTA)
28,000
+21%
5,000
$9.74
$48,700.00
BUY
28 Jan 2022
GRAINGER DAVID J
Chief Innovation Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
27,500
+100%
27,500
$9.05
$248,754.00
BUY
2 Dec 2021
Medicxi Ventures Management (Jersey) Ltd
10% Owner
Centessa Pharmaceuticals plc
(CNTA)
3,936,970
+0%
34,326
$12.82
$440,059.30
BUY
2 Dec 2021
De Rubertis Francesco
Director
Centessa Pharmaceuticals plc
(CNTA)
3,936,970
+0%
34,326
$12.82
$440,059.30
BUY
30 Nov 2021
Medicxi Ventures Management (Jersey) Ltd
10% Owner
Centessa Pharmaceuticals plc
(CNTA)
3,903,440
+2%
97,151
$12.24
$1,189,198.60
BUY
30 Nov 2021
De Rubertis Francesco
Director
Centessa Pharmaceuticals plc
(CNTA)
3,903,440
+2%
97,151
$12.24
$1,189,198.60
BUY
26 Nov 2021
Medicxi Ventures Management (Jersey) Ltd
10% Owner
Centessa Pharmaceuticals plc
(CNTA)
3,808,543
+1%
68,523
$11.64
$797,426.44
BUY
26 Nov 2021
De Rubertis Francesco
Director
Centessa Pharmaceuticals plc
(CNTA)
3,808,543
+1%
68,523
$11.64
$797,426.44
BUY
18 Nov 2021
KANTOFF AARON
Director
Centessa Pharmaceuticals plc
(CNTA)
60,000
+20%
10,000
$11.99
$119,850.00
BUY
16 Nov 2021
SAHA SAURABH
Chief Executive Officer, Director, Officer
Centessa Pharmaceuticals plc
(CNTA)
23,000
+100%
23,000
$12.28
$282,472.20
BUY
16 Nov 2021
Bush Tia L
Chief Quality Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
3,995
+497%
5,000
$12.46
$62,302.25
BUY
2 Jun 2021
CHAO DAVID M
Chief Administrative Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
500
+100%
500
$20.00
$10,000.00
BUY
2 Jun 2021
Medicxi Ventures Management (Jersey) Ltd
10% Owner
Centessa Pharmaceuticals plc
(CNTA)
3,741,609
+19%
600,000
$20.00
$12,000,000.00
BUY
2 Jun 2021
GAP (Bermuda) LTD
10% Owner
Centessa Pharmaceuticals plc
(CNTA)
9,681,818
+18%
1,500,000
$20.00
$30,000,000.00
BUY
2 Jun 2021
Bush Tia L
Chief Quality Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
3,000
+100%
3,000
$20.00
$60,000.00
BUY
2 Jun 2021
Templeman Thomas
Chief Technology Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
250
+100%
250
$20.00
$5,000.00
BUY
2 Jun 2021
HUSSAIN IQBAL J
General Counsel, Officer
Centessa Pharmaceuticals plc
(CNTA)
3,000
+154%
8,500
$20.00
$170,000.00
BUY
2 Jun 2021
GOYAL ARJUN
Director
Centessa Pharmaceuticals plc
(CNTA)
3,825,659
+24%
750,000
$20.00
$15,000,000.00
BUY
2 Jun 2021
Thorell Marella
Chief Accounting Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
1,000
+100%
1,000
$20.00
$20,000.00
BUY
2 Jun 2021
Weinhoff Gregory M
Chief Financial Officer, Officer
Centessa Pharmaceuticals plc
(CNTA)
10,000
+100%
10,000
$20.00
$200,000.00
BUY
29 Jan 2021
De Rubertis Francesco
Director
Centessa Pharmaceuticals plc
(CNTA)
3,741,609
+19%
600,000
$20.00
$12,000,000.00
Home